Stock screener

CRBP

Conviction 18HealthcareScan · Thu, Sep 24, 2026

Corbus Pharmaceuticals Holdings, Inc. (CRBP) closed at $7.47 (-3.55%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 34, RS Rating 14, -61.4% from its 52-week high, -5.1% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

CRBP$7.47-3.55%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
2
Vol MA14 1.66M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Corbus Pharmaceuticals Holdings, Inc.PHARMACEUTICAL PREPARATIONSwww.corbuspharma.com ↗
Price7.47
Change-3.55%
Gap-0.78%
Rel volume0.60×
Avg volume1.33M
Avg $ vol11.09M
SMA 209.09
SMA 509.41
SMA 2009.07
Price vs 50-20.70%
Price vs 200-17.70%
MA stackmixed
50/200 cross—
Supertrenddown · 9.36
RSI (14)34
MACD hist-0.16
MACD cross—
Stoch %K / %D22 / 26
ADX (14)38
+DI / −DI14 / 36
RSI divergenceBearish
MACD divergenceBearish
ATR %8.65%
ADR %7.95%
52w high19.36
52w low6.92
From 52w high-61.44%
Above 52w low+7.88%
New 52w highNo
SqueezeOff
Bollinger width74.86%
%B0.26
Donchian pos21.61%
Donchian high11.60
Donchian low6.33
AVWAP (52w high)9.62
vs AVWAP high-22.37%
AVWAP (52w low)7.31
vs AVWAP low+2.08%
OBV trendDown
Chaikin MF (20)-0.13
Today vs 20d0.60×
Avg vol (14d)1.66M
Avg vol (20d)1.33M
Avg $ vol (20d)11.09M
Market cap144.38M
RS Rating14 / 99
RS 3m (vs SPY)-14.01%
RS 6m (vs SPY)-26.99%
RS line new highNo
Trend template2/8
Technical rank14.2
1 week+2.82%
1 month-34.00%
3 months-9.52%
6 months-10.17%
1 year-35.31%
YTD-5.15%
P/E-1.84
P/B1.41
P/S—
P/FCF-2.24
EPS-5.90
Div yield—
ROE-76.82%
ROA-61.85%
Debt/Eq0.12
Current5.71
EV/EBITDA-1.57
Gross margin—
Net margin—
Rev growth-100.00%
EPS growth-95.32%
Price target36.67
Target upside391.23%
Analyst ratingBuy
Institutional77.24%
Ent. value133.78M
Revenue0
Net income-35.04M
Gross profit—
Free cash flow-64.5M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out18.53M
Employees36
ListedFri, Oct 24, 2014
Free float15.91M
Float %89.7%
Short interest2.25M
Days to cover3.7d
Short volume57.5%
Squeeze score58 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.81 vs −$1.30
Last surprise-39.2% miss
Setup gradeD
Conviction18 / 100
Pattern quality—
Tech rank14.2 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance11.57
Support8.00
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CRBP

All disclosures →
No recent disclosed trades by Congress in CRBP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CRBP · open-market 3 buys · 3 sells

InsiderSideShares
Ben Yong
Director · Common Stock, par value $0.0001 per share · 2026-09-14
Sell2K
Nicacio Leonardo Viana
Chief Medical Officer · Common Stock, par value $0.0001 per share · 2026-08-16
Grant58.33K
Nicacio Leonardo Viana
Chief Medical Officer · Stock options (right to buy) · 2026-08-16
Grant191.68K
Saxena Nishant C
Chief Business Officer · Common Stock, par value $0.0001 per share · 2026-08-11
Buy2.6K
Moran Sean F.
Chief Financial Officer · Common Stock, par value $0.0001 per share · 2026-08-07
Sell12K
Cohen Yuval
Chief Executive Officer · Common Stock, par value $0.0001 per share · 2026-08-07
Sell17K
Saxena Nishant C
Chief Business Officer · Common Stock, par value $0.0001 per share · 2026-06-03
Buy9K
Saxena Nishant C
Chief Business Officer · Common Stock, par value $0.0001 per share · 2026-06-02
Buy4.5K
Saxena Nishant C
Chief Business Officer · Stock options (right to buy) · 2026-05-21
Grant192.3K
Saxena Nishant C
Chief Business Officer · Common Stock, par value $0.0001 per share · 2026-05-21
Grant58.3K

SEC filings

EDGAR filings in CRBP · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.